Clinical images: Three‐dimensional computed tomography imaging of tophaceous gout

Abstract

with late apoptotic and necrotic cells. Eur J Immunol 2003;33: 2853–63. 43. Ogden CA, de Cathehneau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001;194: 781–95. 44. Palaniyar N, Nadesalingam J, Clark H, Shih MJ, Dodds AW, Reid KBM. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannosebinding lectin. J Biol Chem 2004;279:32728–36. 45. Garred P, Thiel S, Madsen HO, Ryder LP, Jensenius JC, Svejgaard A. Gene-frequency and partial protein characterization of an allelic variant of mannan binding-protein associated with low serum concentrations. Clin Exp Immunol 1992;90:517–21. 46. Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA, et al. High-frequencies in African and nonAfrican populations of independent mutations in the mannose binding protein gene [published erratum appears in Hum Mol Genet 1993;2:342]. Hum Mol Genet 1992;1:709–15. 47. Dube R, Rook GA, Steele J, Brealey R, Dwek R, Rademacher T, et al. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 1990;31:431–4. 48. Tomana M, Schrohenloher RE, Reveille JD, Arnett FC, Koopman WJ. Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases. Rheumatol Int 1992;12:191–4. 49. Rook GA, Onyebujoh P, Wilkins E, Ly HM, Alattiyah R, Bahr G, et al. A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunology 1994;81:149–54.